Literature DB >> 34217049

Large underreporting of COPD as cause of death-results from a population-based cohort study.

Anne Lindberg1, Lina Lindberg1, Sami Sawalha1, Ulf Nilsson1, Caroline Stridsman1, Bo Lundbäck2, Helena Backman3.   

Abstract

BACKGROUND: In 2019, WHO estimated COPD to be the third leading cause of death in the world. However, COPD is probably underestimated as cause of death due to the well-known under-diagnosis. AIM: To evaluate the proportion of and factors associated with COPD recorded as cause of death in a long-term follow-up of a population-based COPD cohort.
METHODS: The study population includes all individuals (n = 551) with COPD defined as chronic airway obstruction (post-bronchodilator FEV1/FVC<0.70) + respiratory symptoms identified after re-examinations of four population-based cohorts. Mortality and underlying or contributing cause of death following ICD-10 classification were collected from the Swedish National Board of Health and Welfares register from date of examination in 2002-04 until 2016.
RESULTS: The study sample consisted of 32.3% GOLD 1, 55.9% GOLD 2, and 11.8% GOLD 3-4. The mean follow-up time was 10.3 (SD3.77) years and the cumulative mortality 45.0%. COPD (ICD-10 J43-J44) was recorded on 28.2% (n = 70) of the death certificates (11.1%, 25.7% and 57.1% by GOLD stage), whereof n = 35 had COPD recorded as underlying and n = 35 as contributing cause of death. To have COPD recorded as cause of death was independently associated with ex- and current smoking and a self-reported physician diagnosis of COPD, while male sex, overweight/obesity and higher FEV1% of predicted associated with the absence.
CONCLUSIONS: COPD was largely underreported cause of death. Even among those with severe/very severe disease, COPD was only mentioned on 57.1% of the death certificates.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Epidemiology; Mortality; Physician diagnosis; Risk factor

Mesh:

Year:  2021        PMID: 34217049     DOI: 10.1016/j.rmed.2021.106518

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Factors affecting the length of stay and hospital readmission rates after an acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Qing Wang; Guangsheng Pei; Lin Chen; Zhiyi He
Journal:  Ann Transl Med       Date:  2022-02

Review 2.  Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.

Authors:  Hamad Ghaleb Dailah
Journal:  Molecules       Date:  2022-08-28       Impact factor: 4.927

3.  Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.

Authors:  Ugo Fedeli; Claudio Barbiellini Amidei; Alessandro Marcon; Veronica Casotto; Francesco Grippo; Enrico Grande; Thomas Gaisl; Stefano Barco
Journal:  Int J Environ Res Public Health       Date:  2022-10-07       Impact factor: 4.614

4.  Geographical Differences and Their Associated Factors in Chronic Obstructive Pulmonary Disease Mortality in Japan: An Ecological Study Using Nationwide Data.

Authors:  Tasuku Okui; Jinsang Park
Journal:  Int J Environ Res Public Health       Date:  2021-12-20       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.